Note: Ingredients listed on restricted chemical lists
EC/CAS
202-859-9/100-51-6
Name of the chemical
Benzyl Alcohol
Concentration
≥5 - ≤10
General Information
Revision date
2019-08-21
Product name
Aerowave 2501 Filler
1.2.1 Relevant identified uses
Professional application of coatings and inks
1.2.2. Uses advised against
Reason
Emergency telephone
+44 (0)191 469 6111, +44 (0)191 438 3711, +44 (0)344 892 0111, +353 (0)1 809 2566
Icons in SDS
Company Information
company name
International Paint Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sdsfellinguk@akzonobel.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H317, H319
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
Causes serious eye irritation. May cause an allergic skin reaction.
Precautionary statements
General Not applicable.
Prevention
Wear protective gloves. Wear eye or face protection. Avoid breathing vapour.
Response
IF ON SKIN: Take off contaminated clothing and wash it before reuse. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
Storage
Not applicable.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Hazardous Ingredients
Propylidynetrimethanol, ethoxylated, esters with acrylic acid
Supplemental label elements
elements
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Eye Irrit. 2, H319 Skin Sens. 1, H317 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
